Novocure has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for the use of its portable Optune ...

Novocure (NASDAQ: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Lua® for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult ...

Japan’s MHLW approves Novocure’s Optune Lua to treat unresectable advanced/recurrent non-small cell lung cancer: Baar, Switzerland Tuesday, September 16, 2025, 17:00 Hrs [IST] ...

An announcement from NovoCure ( ($NVCR) ) is now available. On September 15, 2025, Novocure announced that Japan’s Ministry ...

Novocure (Nasdaq:NVCR) announced today that it received regulatory approval in Japan for its Optune Lua wearable device.

The La Quinta grad led the Blackhawks to a pair of CIF titles while setting some huge valley records along the way.

Novocure (NVCR) announced that Japan’s Ministry of Health, Labour and Welfare approved Optune Lua for concurrent use with ...

This year’s Big E begins Friday, Sept. 12, and runs for 17 days through Sept. 28.

I le 50 tausaga lenei talu ona tuto’atasi le malo Papua Niu Kini, o loo feagai pea lea atunu’u ma fa’afitauli i le fetaua’i o ...

The 18,500-square-foot building in Tacoma includes a library, a commercial kitchen, new performance space and more.

NovoCure Limited ( NASDAQ: NVCR) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 PM EDT ...